Protalix BioTherapeutics ...

AMEX: PLX · Real-Time Price · USD
1.54
0.06 (4.05%)
At close: Aug 18, 2025, 3:59 PM
1.54
0.00%
After-hours: Aug 18, 2025, 07:06 PM EDT

Protalix BioTherapeutics Revenue

Protalix BioTherapeutics reported an annual revenue of $53.4M, reflecting a -18.47% growth. For the quarter ending March 31, 2025, Protalix BioTherapeutics generated $10.11M in revenue.
Revenue (ttm)
53.4M
Revenue Growth
-18.47%
Price / Sales Ratio
2.55
Revenue / Employee
250.7K
Employees
213
Market Cap
122.59M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 53.4M -18.47%
Dec 31, 2023 65.49M +37.48%
Dec 31, 2022 47.64M +24.22%
Dec 31, 2021 38.35M -39.03%
Dec 31, 2020 62.9M +15.00%
Dec 31, 2019 54.69M +59.73%
Dec 31, 2018 34.24M +62.44%
Dec 31, 2017 21.08M +129.13%
Dec 31, 2016 9.2M +110.79%
Dec 31, 2015 4.36M -71.21%
Dec 31, 2014 15.16M +31.68%
Dec 31, 2013 11.51M -66.56%
Dec 31, 2012 34.42M +310.49%
Dec 31, 2011 8.39M -25.42%
Dec 31, 2010 11.24M +2797.94%
Dec 31, 2009 388K +Infinity%
Dec 31, 2008 0 n/a
Dec 31, 2007 0 -100.00%
Dec 31, 2006 150K n/a
Dec 31, 2005 150K -65.12%
Dec 31, 2004 430K +Infinity%
Dec 31, 2003 0 n/a
Dec 31, 2002 0 n/a
Dec 31, 2001 0 n/a
Dec 31, 2000 0 -100.00%
Dec 31, 1999 3.56M -55.76%
Dec 31, 1998 8.04M +Infinity%
Dec 31, 1997 0 n/a
Dec 31, 1996 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.